Tony W. Ho

Research interests

Publications

• CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2031054

• Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.72.1340

• Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

  Neurology · 2014 · https://doi.org/10.1212/wnl.0000000000000771

• The Parkinson Progression Marker Initiative (PPMI)

  Progress in Neurobiology · 2011 · https://doi.org/10.1016/j.pneurobio.2011.09.005

• CGRP and its receptors provide new insights into migraine pathophysiology

  Nature Reviews Neurology · 2010 · https://doi.org/10.1038/nrneurol.2010.127

• Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

  Brain · 1995 · https://doi.org/10.1093/brain/118.3.597

• Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China

  Annals of Neurology · 1993 · https://doi.org/10.1002/ana.410330402

Current projects

No projects listed.